Advertisement
News
Subscribe to MDT Magazine News

Adeona's Multiple Sclerosis Trial Receives $409,426 Grant

March 28, 2011 3:34 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., March 28, 2011 /- Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that the ongoing clinical trial of its Trimesta™ (oral estriol) drug candidate has received an additional...

TOPICS:

Adeona to Host 2010 Year End Investor Conference Call

March 28, 2011 3:34 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., March 28, 2011 /- Adeona Pharmaceuticals, Inc. (Amex: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it will hold its 2010 year end investor conference call on Thursday, March 31, 2011, at 4:30pm EDT. James S....

TOPICS:

Health Care Reforms Slow to Impact Real Estate

March 27, 2011 11:35 pm | by San Diego Business Journal | Comments

A year after landmark national health care reforms were signed into law, local observers say the impact on medical-related real estate has yet to be seen on a large scale.

TOPICS:
Advertisement

Dental Biotech Firm Departs With a Smile

March 27, 2011 11:33 pm | by San Diego Business Journal | Comments

After finding a buyer for its only product, local dental biotech company Novalar Pharmaceuticals Inc. will cease operations at the end of the month.

TOPICS:

Certain breast cancer patients worry excessively about recurrence

March 27, 2011 9:38 pm | by EurekAlert | Comments

(Wiley-Blackwell) A new study has found that certain types of women with early stage breast cancer are vulnerable to excessive worrying about cancer recurrence. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study also indicates that...

TOPICS:

Study finds changes in incidence of end-stage renal disease from lupus nephritis

March 27, 2011 9:32 pm | by EurekAlert | Comments

(Wiley-Blackwell) New research documenting changes in the incidence and outcomes of end-stage renal disease (ESRD) in the US between 1995 and 2006, found a significant increase in incidence rates among patients 5 to 39 years of age and in African Americans. A second related study revealed...

TOPICS:

New site lets employers put health care out to bid

March 27, 2011 7:45 am | by HOLLY RAMER - Associated Press - Associated Press | Comments

Self-insured businesses looking to cut out the middleman when it comes to health care have a new way to solicit bids directly from doctors or hospitals.Created by a doctor, a lawyer and a former benefits manager, Open Health Market is an online matchmaker of sorts: Employers submit requests for...

Organizers pick key presentations at ACS 241st National Meeting & Exposition

March 27, 2011 4:37 am | by EurekAlert | Comments

(American Chemical Society) Organizers of the technical program at the ACS's 241st National Meeting & Exposition have identified these highlights from their own division or committee's presentations. The technical program is a journalistic treasure trove for spot news, features,...

TOPICS:
Advertisement

Chinese Army Established the First Chest Pain Rescue Network in China by Using IVT mHealth System

March 26, 2011 5:33 pm | by Bio-Medicine.Org | Comments

GUANGZHOU, China, March 27, 2011 /PRNewswire-Asia/ -- Guangzhou General Hospital of Peoples Liberation Army (PLA) made a landmark announcement that the first Chinese regional military and civilian coordinated Chest Pain Rescue Network using IVT mobile health (mHealth) system is now in...

TOPICS:

Iso-Tex Gets FDA Warning Over Sterility, Contamination Issues

March 25, 2011 2:37 pm | by U.S. Food & Drug Administration | Comments

Friendswood, Texas-based Iso-Tex Diagnostics has been handed an FDA warning letter for good manufacturing practice violations related to radiopharmaceutical diagnostic agents.

Data Shortfalls for Imports Are Worrying CDRH

March 25, 2011 2:37 pm | by U.S. Food & Drug Administration | Comments

CDRH is growing increasingly concerned with the number of imported devices that lack sufficient U.S. entry data.

Mersana moves anti-cancer drug target along in trials

March 25, 2011 11:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Mersana Therapeutics Inc., a Cambridge cancer therapeutics developer, has begun a Phase 1b extension study of its treatment for second-line gastric cancer and second- and third-line non-small cell lung cancer.

TOPICS:

AACR honors eminent researchers

March 25, 2011 11:33 am | by EurekAlert | Comments

(American Association for Cancer Research) The American Association for Cancer Research will recognize leading cancer researchers whose work has significantly contributed to progress in the fight against cancer at the AACR 102nd Annual Meeting 2011. Each recipient will present an...

TOPICS:

Medtronic gets approval for heart products

March 25, 2011 10:45 am | by The Associated Press | Comments

Medical device maker Medtronic Inc. said Friday it received Food & Drug Administration for two heart pacemaker systems.The company said it received approval for its Consulta and Syncra cardiac resynchronization therapy-pacemaker systems. It said Consulta is the first cardiac resynchronization...

BG Medicine lands heart test deal

March 25, 2011 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

BG Medicine Inc., a Waltham developer of cardiac diagnostics, has teamed with Health Diagnostic Laboratory Inc. in a deal in which BG's Galectin-3 test will complement HDL's testing services for the galectin-3 protein.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading